3 out of 4 commercially insured patients on mealtime insulin have coverage for the Dexcom G6 Continuous Glucose Monitoring (CGM) System
Zero fingersticks* or scanning required.
Dexcom CGM use is clinically proven to lower A1C, reduce hyper- and hypoglycemia, and increase time in range.
Includes a predictive Urgent Low Soon alert and a suite of customizable high and low glucose alerts.
* If your glucose alerts and readings from Dexcom G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
92% of surveyed US patients said that Dexcom G6 is easy to use.
Dexcom, Inc. is the leader in transforming diabetes care and management by providing continuous glucose monitoring (CGM) technology to help patients and healthcare professionals better manage diabetes.
This post is related to:
Merchandising: OTC Products, Vitamins, Supplements
